Aumolertinib Plus Apatinib Versus Aumolertinib in Untreated, EGFR-Mutant, Advanced NSCLC (ATTENTION): A Randomized, Multi-Center, Phase 2 Study

• DOI: 10.2139/ssrn.5217014
• Publication Date: 2025-04-15T16:00:22Z
• Authors: Fan Zhang; Zhendong Zheng; Hong-Mei Zhang; Xiaolong Yan; Zhefeng Liu; Fan Yang; Juyi Wen; Xin Gan; Lin Wu; Shundong Cang; Hongmei Wang; Jun Zhao; Liang Peng; Xiaosong Li; Zaiwen Fan; Ge Shen; Qiong Zhou; Jinjing Zou; Yu Xu; Lei Zhang; Mingfang Zhao; Shangli Cai; Yi Hu
• Keywords: Apatinib; Center (category theory)